The
following potentially dilutive securities have not been included in the computation of diluted net loss per share for the six months
ended June 30, 2026 and June 30, 2025, as the result would be anti-dilutive:
Schedule of Earnings Per Share, Basic and Diluted
| | |
June 30, | | |
June 30, | |
| | |
2026 | | |
2025 | |
| Stock options | |
| 24,827 | | |
| 25,106 | |
| Restricted stock units | |
| - | | |
| 10 | |
| Series A preferred stock | |
| 2 | | |
| 2 | |
| Series F preferred stock | |
| - | | |
| 654,000 | |
| Common stock warrants | |
| 2,992 | | |
| 1,965,178 | |
| Total shares excluded from calculation | |
| 27,821 | | |
| 2,644,296 | |
|